Press Announcements > FDA approves implantable device to treat moderate to severe central sleep apnea

Press Announcements > FDA approves implantable device to treat moderate to severe central sleep apnea

FDA approves implantable device to treat moderate to severe central sleep apnea

The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing. Continue reading.